0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bipolar Disorder Therapeutics Market by Drug Class, Therapy Type, Disease Phase, Distribution Channel, Route Of Administration, Patient Age Group, Disorder Type - Global Forecast to 2030- Product Image
Bipolar Disorder Therapeutics Market by Drug Class, Therapy Type, Disease Phase, Distribution Channel, Route Of Administration, Patient Age Group, Disorder Type - Global Forecast to 2030- Product Image
Sale

Bipolar Disorder Therapeutics Market by Drug Class, Therapy Type, Disease Phase, Distribution Channel, Route Of Administration, Patient Age Group, Disorder Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010914
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bipolar Disorder Therapeutics Market continues to evolve, presenting a complex and dynamic landscape for senior decision-makers navigating clinical, regulatory, and commercial environments. This report delivers actionable insights for optimizing strategic planning across therapies, technologies, and markets in bipolar disorder treatment.

Market Snapshot: Bipolar Disorder Therapeutics

The bipolar disorder therapeutics market grew from USD 6.37 billion in 2024 to USD 6.72 billion in 2025. It is expected to expand at a CAGR of 5.39%, reaching USD 8.73 billion by 2030. Senior executives face a landscape marked by ongoing innovation, supply chain adjustments, and heightened scrutiny on value-based outcomes. As emerging therapies and digital platforms integrate with evolving care models, stakeholders need a holistic view to inform leadership decisions and investments.

Scope & Segmentation

  • Drug Classes: Antidepressants (including SNRIs, SSRIs, TCAs), atypical antipsychotics (aripiprazole, olanzapine, quetiapine, risperidone), and mood stabilizers (carbamazepine, lamotrigine, lithium, valproate).
  • Therapy Types: Combination regimens (atypical antipsychotic with antidepressant, mood stabilizer with either antidepressant or antipsychotic) and monotherapy.
  • Disease Phases: Acute treatment and maintenance therapy, addressing both emergency intervention and long-term management needs.
  • Distribution Channels: Hospital pharmacy, online pharmacy, and retail pharmacy platforms shaping therapy access and adherence support.
  • Routes of Administration: Injectable and oral therapies, with considerations for patient convenience and adherence.
  • Patient Age Groups: Distinct approaches for adult, geriatric, and pediatric patients, reflecting safety, dosing, and efficacy nuances.
  • Disorder Type: Includes bipolar I, bipolar II, cyclothymia, mixed episode, and rapid cycling variants for comprehensive clinical development and marketing strategy alignment.
  • Regions Covered: Americas (with a focus on United States states and Latin America), Europe, Middle East & Africa (with diverse national systems), and Asia-Pacific (highlighting China, India, Japan, and more).
  • Company Developments: Insights for Otsuka Pharmaceutical, AstraZeneca, AbbVie, Johnson & Johnson, Sumitomo Dainippon, Eli Lilly, GlaxoSmithKline, Merck, Novartis, and H. Lundbeck, among other sector leaders.

Bipolar Disorder Therapeutics Market: Key Takeaways

  • Advancements in neurogenetics and digital health tools are expanding opportunities for precision and real-time intervention, moving treatment closer to individualized care pathways.
  • Therapy regimens that combine pharmacological innovations with digital adherence support present new models for improving both symptom management and long-term outcomes.
  • Strategic collaborations between pharmaceutical companies, biotechnology innovators, and academic consortia are accelerating the pipeline for novel agents, particularly in neuroinflammation and synaptic plasticity.
  • Payer requirements for demonstrating sustained value and quality-of-life improvements are shaping evidence-generation and contracting strategies in highly competitive markets.
  • Changing distribution and administration patterns—such as increased use of digital and outpatient platforms—are shifting the focus toward patient accessibility and operational efficiency.
  • Adapting to region-specific regulatory expectations and reimbursement models is crucial for geographic expansion and optimizing market entry timelines.

Tariff Impact: Supply Chain & Cost Structure

New United States tariff structures in 2025 have affected the bipolar disorder therapeutics supply chain. Increased costs on active pharmaceutical ingredients and excipients are leading manufacturers to rethink sourcing, procurement, and manufacturing locations. Larger organizations leverage global scale to absorb cost increases, while smaller firms face more significant challenges maintaining competitive pricing. Strategic partnerships, supplier negotiations, and localized manufacturing initiatives are gaining momentum to support supply resilience and sustained market access.

Methodology & Data Sources

The research approach integrates comprehensive reviews of peer-reviewed journals, regulatory filings, clinical registries, and government data. Primary interviews with key opinion leaders in psychiatry, pharmacology, and health economics complement secondary data. Analytical models, market share analysis, and scenario planning underpin the findings, with validation by industry experts to ensure data integrity.

Why This Report Matters

  • Guides senior leaders in evaluating opportunities amid regulatory, technological, and commercial disruption in bipolar disorder therapeutics.
  • Supports strategic initiatives for portfolio diversification, evidence generation, and access optimization across global regions.
  • Equips decision-makers with credible, actionable insight to align innovation with demonstrable clinical and payer value.

Conclusion

This report delivers a comprehensive and up-to-date analysis for stakeholders advancing bipolar disorder therapeutics. Strategic planning grounded in robust market data and actionable recommendations helps leaders confidently address changing industry priorities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bipolar Disorder Therapeutics Market, by Drug Class
8.1. Introduction
8.2. Antidepressants
8.2.1. SNRIs
8.2.2. SSRIs
8.2.3. TCAs
8.3. Atypical Antipsychotics
8.3.1. Aripiprazole
8.3.2. Olanzapine
8.3.3. Quetiapine
8.3.4. Risperidone
8.4. Mood Stabilizers
8.4.1. Carbamazepine
8.4.2. Lamotrigine
8.4.3. Lithium
8.4.4. Valproate
9. Bipolar Disorder Therapeutics Market, by Therapy Type
9.1. Introduction
9.2. Combination Therapy
9.2.1. Atypical Antipsychotic And Antidepressant
9.2.2. Mood Stabilizer And Antidepressant
9.2.3. Mood Stabilizer And Atypical Antipsychotic
9.3. Monotherapy
10. Bipolar Disorder Therapeutics Market, by Disease Phase
10.1. Introduction
10.2. Acute Treatment
10.3. Maintenance Therapy
11. Bipolar Disorder Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Bipolar Disorder Therapeutics Market, by Route Of Administration
12.1. Introduction
12.2. Injectable
12.3. Oral
13. Bipolar Disorder Therapeutics Market, by Patient Age Group
13.1. Introduction
13.2. Adult
13.3. Geriatric
13.4. Pediatric
14. Bipolar Disorder Therapeutics Market, by Disorder Type
14.1. Introduction
14.2. Bipolar I
14.3. Bipolar II
14.4. Cyclothymia
14.5. Mixed Episode
14.6. Rapid Cycling
15. Americas Bipolar Disorder Therapeutics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Bipolar Disorder Therapeutics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Bipolar Disorder Therapeutics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Otsuka Pharmaceutical Co., Ltd.
18.3.2. AstraZeneca PLC
18.3.3. AbbVie Inc.
18.3.4. Johnson & Johnson
18.3.5. Sumitomo Dainippon Pharma Co., Ltd.
18.3.6. Eli Lilly and Company
18.3.7. GlaxoSmithKline plc
18.3.8. Merck & Co., Inc.
18.3.9. Novartis AG
18.3.10. H. Lundbeck A/S
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BIPOLAR DISORDER THERAPEUTICS MARKET MULTI-CURRENCY
FIGURE 2. BIPOLAR DISORDER THERAPEUTICS MARKET MULTI-LANGUAGE
FIGURE 3. BIPOLAR DISORDER THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BIPOLAR DISORDER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BIPOLAR DISORDER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIPOLAR DISORDER THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY SNRIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY SSRIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY TCAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ARIPIPRAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY OLANZAPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY QUETIAPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RISPERIDONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY CARBAMAZEPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY LAMOTRIGINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY LITHIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY VALPROATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTIC AND ANTIDEPRESSANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZER AND ANTIDEPRESSANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZER AND ATYPICAL ANTIPSYCHOTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ACUTE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MAINTENANCE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY BIPOLAR I, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY BIPOLAR II, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY CYCLOTHYMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MIXED EPISODE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY RAPID CYCLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 142. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 143. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 144. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 145. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 147. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 153. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 155. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 156. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 157. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 158. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 159. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 160. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 163. FRANCE BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 175. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 176. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 177. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 178. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 179. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 180. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 181. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 182. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 185. ITALY BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 187. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 188. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 189. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 190. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 191. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 192. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 193. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. SPAIN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 230. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 231. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 232. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 233. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 234. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 235. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 236. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 237. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. DENMARK BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 252. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 253. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 254. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 255. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 256. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 257. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 258. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 259. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 262. QATAR BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 263. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 264. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 265. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 266. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 269. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 270. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 273. FINLAND BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISEASE PHASE, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DISORDER TYPE, 2018-2030 (USD MILLION)
TABLE 296. EGYPT BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 297. EGYPT BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, 2018-2030 (USD MILLION)
TABLE 298. EGYPT BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY ATYPICAL ANTIPSYCHOTICS, 2018-2030 (USD MILLION)
TABLE 299. EGYPT BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY MOOD STABILIZERS, 2018-2030 (USD MILLION)
TABLE 300. EGYPT BIPOLAR DISORDER THERAPEUTICS MARKET SIZE, BY THERAPY TY

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

The companies profiled in this Bipolar Disorder Therapeutics market report include:
  • Otsuka Pharmaceutical Co., Ltd.
  • AstraZeneca PLC
  • AbbVie Inc.
  • Johnson & Johnson
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • H. Lundbeck A/S

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.72 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.73 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • 380 Pages
  • Global
From
EUR$5,850USDGBP
Bipolar Disorder Therapeutics Market Report 2025 - Product Image

Bipolar Disorder Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025 - Product Image

Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Bipolar Depression - Pipeline Insight, 2025 - Product Image

Bipolar Depression - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
EUR$1,250USDGBP

About the Bipolar Disorder Drug Market

The Bipolar Disorder Drug market is a subset of the Mental Disorders Drugs market, which includes medications used to treat a variety of mental health conditions. Bipolar Disorder Drugs are used to treat the symptoms of bipolar disorder, a mental health condition characterized by extreme shifts in mood, energy, and activity levels. These drugs are typically prescribed to help manage the manic and depressive episodes associated with the disorder. Commonly prescribed Bipolar Disorder Drugs include mood stabilizers, antipsychotics, and antidepressants. The Bipolar Disorder Drug market is highly competitive, with a range of pharmaceutical companies offering products to treat the condition. Some of the major players in the market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more